KM
Insider
Keith S Manchester
DirectorKeith S Manchester (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $56.4M of ROIV (1,638,163 sh across 6 lots, as filed), executed Jun 26.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$154.5M
shares × price, as filed
Last traded
Jun 30
Filed Jun 30
Median ADV $222.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $154.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
ROIVRecent filings
ROIVSALE
Roivant Sciences Ltd.
View filing →
$56.4M1,638,163 sh across 6 lots
Exec Jun 26
Filed Jun 30 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $32.7M
1,225,784 sh across 5 lots
Exec Feb 11
Filed Feb 13 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $39.1M
1,694,614 sh across 5 lots
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $26.3M
1,300,000 sh across 4 lots
Exec Nov 19 2025
Filed Nov 21 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $5.9M
503,000 sh across 2 lots
Exec Sep 24 2024
Filed Sep 26 2024 · 5:30 PM ET